Bi TM. Relationship between thyroid hormone levels and metabolic dysfunction associated steatotic liver disease in patients with type 2 diabetes: a clinical study. Medicine (Baltimore). 2024;103(26):e38643. https://doi.org/10.1097/MD.0000000000038643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lazarus JV, Newsome PN, Francque SM, et al. Reply: a multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2024;79:E93–4.

Article  PubMed  Google Scholar 

Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–9. https://doi.org/10.1016/j.jhep.2020.03.039.

Article  PubMed  Google Scholar 

Gong F, Targher G. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010–2021. JHEP Rep. 2025;7(3):101271. https://doi.org/10.1016/j.jhepr.2024.101271.

Article  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.

Article  PubMed  Google Scholar 

Ma D, Zhao P, Gao J, Guo X, Han M, Zan X, et al. The correlation between impaired thyroid hormone sensitivity and diabetic nephropathy in euthyroid patients with type 2 diabetes mellitus. Diabetes, Metab Syndr Obes. 2025;18:1207–21. https://doi.org/10.2147/DMSO.S507750.

Article  PubMed  PubMed Central  Google Scholar 

Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care. 2019;42(2):303–10. https://doi.org/10.2337/dc18-1410.

Article  CAS  PubMed  Google Scholar 

Liu H, Xing Y, Nie Q, Li Z, Meng C, Ma H. Association between sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:2153–63. https://doi.org/10.2147/DMSO.S420872.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang S, Lai S, Wang Z, et al. Thyroid feedback quantile-based index correlates strongly to renal function in euthyroid individuals. Ann Med. 2021;53(1):1945–55. https://doi.org/10.1080/07853890.2021.1993324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yagi H, Pohlenz J, Hayashi Y, et al. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors β, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3′-triiodothyroinine binding affinity. J Clin Endocrinol Metab. 1997;82(5):1608–14. https://doi.org/10.1210/jcem.82.5.3945.

Article  CAS  PubMed  Google Scholar 

Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH index. Clin Endocrinol. 2009;71(4):529–34. https://doi.org/10.1111/j.1365-2265.2009.03534.x.

Article  CAS  Google Scholar 

Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. https://doi.org/10.1186/s12944-017-0409-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corica D, Licenziati MR, Calcaterra V, et al. Central and peripheral sensitivity to thyroid hormones and glucose metabolism in prepubertal children with obesity: pilot multicenter evaluation. Endocrine. 2023;80(2):308–11. https://doi.org/10.1007/s12020-022-03276-5.

Article  CAS  PubMed  Google Scholar 

Zhang X, Chen Y, Ye H, et al. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes. Endocrine. 2023;80(2):366–79. https://doi.org/10.1007/s12020-022-03279-2.

Article  CAS  PubMed  Google Scholar 

Gökmen FY, Ahbab S, Ataoğlu HE, et al. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics. 2016;71(4):221–5. https://doi.org/10.6061/clinics/2016(04)08.

Article  PubMed  PubMed Central  Google Scholar 

Chen YL, Tian S, Wu J, et al. Impact of thyroid function on the prevalence and mortality of metabolic dysfunction-associated fatty liver disease. J Clin Endocrinol Metab. 2023;108(7):e434–43. https://doi.org/10.1210/clinem/dgad016.

Article  CAS  PubMed  Google Scholar 

Marschner RA, Arenhardt F, Ribeiro RT, et al. Influence of altered thyroid hormone mechanisms in the progression of metabolic dysfunction associated with fatty liver disease (MAFLD): a systematic review. Metabolites. 2022;12(8):675. https://doi.org/10.3390/metabo12080675.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jun JE, Jee JH, Bae JC, et al. Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study. Thyroid. 2017;27(1):29–38. https://doi.org/10.1089/thy.2016.0171.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Li J, Liu H. Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function. BMC Endocr Disord. 2022;22(1):144. https://doi.org/10.1186/s12902-022-01050-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2021;32(7):500–14. https://doi.org/10.1016/j.tem.2021.04.008.

Article  CAS  PubMed  Google Scholar 

Albhaisi S, Chowdhury A, Sanyal AJ. Non-alcoholic fatty liver disease in lean individuals. JHEP Rep. 2019;1(4):329–41. https://doi.org/10.1016/j.jhepr.2019.08.002.

Article  PubMed  PubMed Central  Google Scholar 

Lai S, Li J, Wang Z, et al. Sensitivity to thyroid hormone indices are closely associated with NAFLD. Front Endocrinol. 2021;12:766419. https://doi.org/10.3389/fendo.2021.766419.

Article  Google Scholar 

Mohammed Hussein SM, AbdElmageed RM. The relationship between type 2 diabetes mellitus and related thyroid diseases. Cureus. 2021. https://doi.org/10.7759/cureus.20697.

Article  PubMed  PubMed Central  Google Scholar 

Wan H, Yu G, Xu S, et al. Central sensitivity to free triiodothyronine with MAFLD and its progression to liver fibrosis in euthyroid adults. J Clin Endocrinol Metab. 2023. https://doi.org/10.1210/clinem/dgad186.

Article  PubMed  PubMed Central  Google Scholar 

Ogbonna SU, Ezeani IU. Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus. Front Endocrinol. 2019. https://doi.org/10.3389/fendo.2019.00440.

Article  Google Scholar 

Hotamisligil GkS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science. 1996;271(5249):665–70. https://doi.org/10.1126/science.271.5249.665.

Article  CAS  PubMed  Google Scholar 

Panicker V, Cluett C, Shields B, et al. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab. 2008;93(8):3075–81. https://doi.org/10.1210/jc.2008-0397.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iwamoto Y, Kimura T, Tatsumi F, et al. Effect of hyperglycemia-related acute metabolic disturbance on thyroid function parameters in adults. Front Endocrinol. 2022;13:869869. https://doi.org/10.3389/fendo.2022.869869.

Article  Google Scholar 

Sinha RA, Bruinstroop E, Yen PM. Actions of thyroid hormones and thyromimetics on the liver. Nat Rev Gastroenterol Hepatol. 2025;22(1):9–22.